ADMS - Adamas Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $13.44. This is a potential upside of $13.44 (0%) from yesterday's end of day stock price of $0.

Adamas Pharmaceuticals's activity chart (see below) currently has 64 price targets and 43 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.04% with an average time for these price targets to be met of 129.5 days.

Most recent stock forecast was given by CARL BYRNES from on 17-Nov-2021. First documented stock forecast 23-Dec-2015.

Split History since 2000:

1/18/00 3 for 2

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2 years 3 months 13 days ago

0/1 (0%)

$34.88 (99.32%)

Hold

14

2 years 4 months 17 days ago

3/7 (42.86%)

$9.25 (194.74%)

87

Buy

6

$-2.22 (-27.01%)

20

2 years 4 months 18 days ago

0/2 (0%)

$3.2 (23.94%)

Hold

7

$-1.22 (-14.84%)

7

2 years 4 months 18 days ago

3/8 (37.5%)

$-1.08 (-13.37%)

124

Buy

9.1

$0.88 (10.71%)

12

2 years 4 months 18 days ago

0/7 (0%)

$1.02 (12.62%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADMS (Adamas Pharmaceuticals) average time for price targets to be met?

On average it took 129.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.04

Which analyst has the current highest performing score on ADMS (Adamas Pharmaceuticals) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on ADMS (Adamas Pharmaceuticals)?

Jason Butler works at JMP and has 2 price targets and 3 ratings on ADMS

Which analyst is the currently most bullish on ADMS (Adamas Pharmaceuticals)?

Raghuram Selvaraju with highest potential upside - $0.88

Which analyst is the currently most reserved on ADMS (Adamas Pharmaceuticals)?

Irina Koffler with lowest potential downside - -$3.22

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?